share_log

Eiger BioPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Propel Bio Management, LLC(5.40%),Leen Kawas(5.40%)

SEC ·  Aug 15, 2023 18:00
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.